GlassScriptPhysician profile
Ha Vu
NPI 1760616551
$1,627.04
in general payments reported to CMS, 2019-2025
19 companies · $18.77 in 2025
The $18.77 reported for 2025 was less than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $455 · 2020: $211 · 2021: $401 · 2022: $333 · 2023: $178 · 2024: $29.87 · 2025: $18.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $227.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $226.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $420.87 | 2021-2023 | Vraylar |
| Neurocrine Biosciences, INC. | $155.77 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $141.34 | 2019-2021 | |
| Allergan, INC. | $110.21 | 2019-2020 | |
| Lundbeck LLC | $104.47 | 2021-2023 | Abilify Maintena |
| Janssen Pharmaceuticals, INC | $102.43 | 2019-2023 | Spravato |
| Sunovion Pharmaceuticals INC. | $78.10 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $76.39 | 2019-2025 | Rexulti |
| Alkermes, INC. | $75.55 | 2019-2020 | |
| Shire North American Group INC | $65.25 | 2019 | |
| Bausch Health US, LLC | $55.83 | 2019-2022 | |
| Almatica Pharma LLC | $47.93 | 2021-2023 | Loreev Xr |
| Eisai INC. | $37.77 | 2020-2021 | |
| Ironshore Pharmaceuticals INC. | $36.32 | 2019 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $31.87 | 2021-2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vanda Pharmaceuticals INC. | $29.87 | 2024 | Fanapt |
| Indivior INC. | $23.94 | 2020 | |
| Neos Therapeutics, LP | $19.90 | 2022 | |
| Avanir Pharmaceuticals, INC. | $13.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ha Vu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.